Literature DB >> 18305268

Systemic lupus erythematosus.

Anisur Rahman1, David A Isenberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18305268     DOI: 10.1056/NEJMra071297

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  590 in total

1.  The microRNA miR-23b suppresses IL-17-associated autoimmune inflammation by targeting TAB2, TAB3 and IKK-α.

Authors:  Shu Zhu; Wen Pan; Xinyang Song; Yan Liu; Xinrui Shao; Yuanjia Tang; Dong Liang; Dongyi He; Honglin Wang; Wenjun Liu; Yufang Shi; John B Harley; Nan Shen; Youcun Qian
Journal:  Nat Med       Date:  2012-07       Impact factor: 53.440

2.  Successes, Challenges and Lessons Learned: Community-engaged research with South Carolina's Gullah population.

Authors:  Ida J Spruill; Renata Serricchio Leite; Jyotika K Fernandes; Diane L Kamen; Marvella E Ford; Carolyn Jenkins; Kelly J Hunt; Jeannette O Andrews
Journal:  Gateways       Date:  2013

3.  Work loss and work entry among persons with systemic lupus erythematosus: comparisons with a national matched sample.

Authors:  Edward Yelin; Chris Tonner; Laura Trupin; Pantelis Panopalis; Jinoos Yazdany; Laura Julian; Patricia Katz; Lindsey A Criswell
Journal:  Arthritis Rheum       Date:  2009-02-15

4.  Increased ribonuclease expression reduces inflammation and prolongs survival in TLR7 transgenic mice.

Authors:  Xizhang Sun; Alice Wiedeman; Nalini Agrawal; Thomas H Teal; Lena Tanaka; Kelly L Hudkins; Charles E Alpers; Silvia Bolland; Matthew B Buechler; Jessica A Hamerman; Jeffrey A Ledbetter; Denny Liggitt; Keith B Elkon
Journal:  J Immunol       Date:  2013-02-04       Impact factor: 5.422

5.  Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort.

Authors:  Maria I Danila; Guillermo J Pons-Estel; Jie Zhang; Luis M Vilá; John D Reveille; Graciela S Alarcón
Journal:  Rheumatology (Oxford)       Date:  2009-02-20       Impact factor: 7.580

Review 6.  Drugs in early clinical development for Systemic Lupus Erythematosus.

Authors:  Mariana Postal; Nailú Angélica Sinicato; Simone Appenzeller; Timothy B Niewold
Journal:  Expert Opin Investig Drugs       Date:  2016-04-07       Impact factor: 6.206

7.  Detection of dynamic frequencies of Th17 cells and their associations with clinical parameters in patients with systemic lupus erythematosus receiving standard therapy.

Authors:  Zhenke Wen; Lin Xu; Wei Xu; Sidong Xiong
Journal:  Clin Rheumatol       Date:  2014-05-10       Impact factor: 2.980

Review 8.  Therapeutic potential of HO-1 in autoimmune diseases.

Authors:  Bao-Zhu Li; Biao Guo; Hai-Yan Zhang; Juan Liu; Sha-Sha Tao; Hai-Feng Pan; Dong-Qing Ye
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

9.  miR-210 expression in PBMCs from patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Q Huang; S-S Chen; J Li; S-S Tao; M Wang; R-X Leng; H-F Pan; D-Q Ye
Journal:  Ir J Med Sci       Date:  2017-05-30       Impact factor: 1.568

10.  E3 ligase FBXW7 aggravates TMPD-induced systemic lupus erythematosus by promoting cell apoptosis.

Authors:  Zhenlu Chong; Chunjing Bao; Jia He; Tianxiao Chen; Lijia Zhong; Gaopeng Li; Huanle Li; Lutong Fang; Yinjing Song; Guoxiang Fu; Xuyan Yang; Lihua Lai; Yang Liu; Qingqing Wang
Journal:  Cell Mol Immunol       Date:  2018-10-01       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.